ASCO 2020：11项中国人研究入选口头报告，17项Poster报告

均受世界新的冠流感直接影响，原定于5年底29日~6年底2日在纽约市举行的宾夕法尼亚州临床学才会（ASCO）年才会今年将首次以终点站上基本主办，这是以外最大规模的终点站上晚才会。今天，内阁才会议的简短试题披露，共103个sessions，之西方共有11项数据归纳崭露头角口头报告，17项崭露头角Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

吡咯替尼或拉帕替尼加卡培他松用于HER2+移往性乳腺肺癌（PHOEBE）：一项III期随机试制。

首站：移往性乳腺肺癌

原作者：之西方医学科学院该医院徐兵河数据归纳员、马飞数据归纳员，南京大学另设该医院胡夕春数据归纳员等

简短号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可移植手术三单数乳腺肺癌新的标准外科移植手术后卡培他松维持节拍肌肉注射的III期试制（SYSUCC-001）。

首站：乳腺肺癌—连续性/区域/来进行外科移植手术

原作者：北京大学公共卫生的之中心王树森数据归纳员等

简短号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

并用移往性脑的变异基本特征来预期脑脊液之中循环DNA侦测的概率: 新的领域软件对抗老对手

首站：新的领域软件应对老情况

原作者：李美芹 李德兰等

简短号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

多纳非尼对科特迪瓦拉非尼作为末期肺肺细胞肺癌的一终点站外科移植手术：一项对外开放标签、随机、多的之中心II/III期试制。

首站：呼吸道肺癌—腹腔冠状动脉、胰腺和绝

原作者：四川大学毛脉该医院毕锋数据归纳员、之西方祖国解放军二七该医院秦叔逵数据归纳员等

简短号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

之西方末期肺肺癌病症阿帕替尼二终点站外科移植手术：一项随机、CPA印证、双盲III期数据归纳

首站：呼吸道肺癌—腹腔冠状动脉、胰腺和绝

原作者：之西方祖国解放军二七该医院秦叔逵数据归纳员、四川大学毛脉该医院李秋数据归纳员等

简短号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

末期发作性卵巢肺癌二次肺细胞减灭术的一项随机III期试制：SOC1 / SGOG-OV2。

不定期：儿科肺前列腺癌

原作者：南京大学另设之中山该医院臧荣余数据归纳员等

简短：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈肺癌根治性睾丸移植手术后来进行外科移植手术之中的序贯放肌肉注射对比单独化疗或同步放肌肉注射（STARS数据归纳）：一项随机、印证、对外开放标签的III期试制。

内阁才会议：儿科肺前列腺癌

原作者：北京大学公共卫生的之中心黄鹤数据归纳员、刘继红数据归纳员等

简短号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：来进行吉非替尼对比肌肉注射用于可切除的EGFR突变的N1-N2期NSCLC-随机III期临床试制的最终总体适应环境归纳。

不定期：胃肺癌—非小肺细胞连续性-区域/小肺细胞/其他腰部

原作者：东莞祖国该医院吴一龙数据归纳员等

简短号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR突变；不移往非小肺细胞胃肺癌病症一终点站组氨酸趋化因子抑制剂重新的组建或不重新的组建积极前终点站连续性化疗：III期对外开放标签临床随机试制（SINDAS）的之中期结果（NCT02893332）。

不定期：胃肺癌-非小肺细胞移往

原作者：四川省祖国该医院曾铭数据归纳员等

简短：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对程序性失踪-1（PD-1）的人源化IgG4单克隆抗体重新的组建阿昔替尼用于移往性发炎癌症病症的Ib期数据归纳的总适应环境期和生物体标志物归纳。

不定期：癌症/皮肤肺癌

原作者：北京大学该医院郭军、盛锡楠数据归纳员等

简短：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的稳定性和结果：非新的标准CAR-T肺细胞首次人体内试制外科移植手术发作/难治性T肺细胞急性淋巴肺细胞肺癌（r/r T-ALL）的稳定性和。内阁才会议：联合开发之中的外科移植手术技术-免疫外科移植手术。原作者：王立马等简短：3013宣传片：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利单抗在末期冠状动脉鳞状肺细胞肺癌病症之中的领域：一项随机的对外开放标签II期试制（ORIENT-2）。内阁才会议：呼吸道肺癌-腹腔冠状动脉肺癌、胰腺肺癌和绝道肺癌原作者：徐建明数据归纳员等简短：4511宣传片：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D抗原CAR-T肺细胞对髓母肺细胞瘤的根除性外科移植手术内阁才会议：之大脑皮层原作者：代红久、孙斌、杨东、徐晖、朱结缘、魏佳、郑旭东简短：2522宣传片。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在末期错配修复缺陷病症之中的领域内阁才会议：联合开发之中的外科移植手术学-免疫外科移植手术原作者：沈琳数据归纳员等简短：3021宣传片。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 诱导CD7-CART外科移植手术发作/难治性ACUTE淋巴肺细胞肺癌/失智症的首例人体内临床试制内阁才会议: 联合开发性外科移植手术学-免疫外科移植手术原作者简介：张明志，杨林等简短：3026宣传片: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 罗勒替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度胺（T）重新的组建用于末期实体瘤病症的Ib期数据归纳内阁才会议：发展性外科移植手术学--分子凋亡抗生素和生物体学原作者：龚继芳，沈琳数据归纳员等简短：3523宣传片：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin重新的组建紫杉醇和nedaplatin外科移植手术发作性或移往性冠状动脉鳞状肺细胞肺癌（ESCC）病症的II期数据归纳。内阁才会议：呼吸道肺癌-腹腔冠状动脉、胰腺和绝道肺癌的数据归纳原作者：王志爆冷，李玉红，王德申，王凤华，任超，谭琼 王志爆冷、李玉红、王德深、王凤华、任超、谭琼简短：4522宣传片：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.内阁才会议：呼吸道肺癌-腹腔冠状动脉肺癌、胰腺肺癌和绝管肺癌的二终点站外科移植手术原作者：宋艳等简短：4524宣传片：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种分泌物外体网状RNA分类器用于初始前列腺时侦测高等级肺癌的分泌物外体网状RNA分类器：一项多的之中心的回顾性数据归纳内阁才会议：泌尿系统泌尿系统肺前列腺癌那是肺癌、睾丸肺癌和肺癌原作者简介：Liaoyuan Li等简短：5522宣传片。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 连续性末期宫颈肺癌并发肌肉注射后的来进行肌肉注射内阁才会议: 儿科肺前列腺癌原作者简介： 李珉珉等简短：6031宣传片：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼外科移植手术甲状腺髓性肺癌的相似性：基于ALTER01031试制的归纳。才会话：躯干原作者：天津市该医院高明数据归纳员简短：6526宣传片。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、大小和平均年龄对安洛替尼外科移植手术后病症结局的直接影响: ALTER01031的亚组归纳内阁才会议：躯干原作者：天津市该医院高明数据归纳员简短：6527宣传片。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA归纳预期I-IIIA期非小肺细胞胃肺癌（NSCLC）病症术后发作: GASTO1035和GASTO1018的结果内阁才会议：胃肺癌-非小肺细胞连续性-国际性/小肺细胞/小肺细胞/其他胸科肺前列腺癌原作者：Si-Yu Wang等简短：9023宣传片：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小肺细胞胃肺癌（NSCLC）之中EGFR组氨酸趋化因子抑制剂的新的型耐药功能内阁才会议:胃肺癌-非小肺细胞移往性胃肺癌原作者简介：郑昕，金玲玲，满宇，欧赛金花，才与，薛武，杨少，范敏 郑昕、金玲玲、满宇、欧赛金花、才与、薛武、杨绍、范敏简短：9528宣传片：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1试制之中末期癌症总适应环境的替代终点内阁才会议：癌症/皮肤肺癌原作者：聂润聪，袁书爆冷，李元芳，陈英波，周志伟 聂润聪、袁书爆冷、李元芳、陈英波、周志伟简短：10030宣传片：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼外科移植手术发作或移往性病变恶性骨病症的II期数据归纳内阁才会议： 白血病原作者：唐丽娜，牛晓辉，陈赓，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、朝臣、蔡启庆、涂崇奇、范正福、杨瑶简短：11525宣传片。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 初步口碑安罗替尼在末期白血病病症多终点站外科移植手术之中的稳定性和。内阁才会议：白血病原作者：姚伟涛，陈家爆冷，张春，王欣，杜新的辉，田志浩，牛晓颖 姚伟涛、陈家爆冷、张春、王鑫、杜鑫辉、田志超、牛晓英简短：11526宣传片：414